Brazil approves use and marketing of COVID-19 self-tests

The collegiate board of Brazil’s national drug regulator Anvisa unanimously approved on Friday (Jan. 28) the use and marketing of COVID-19 self-tests in Brazil.

The decision was made after the Ministry of Health has sent Anvisa information at its request, on January 19, about clarification regarding the inclusion of the self-test in public testing policies for COVID-19.